Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|April 28, 2010
FAM-MDR: a flexible family-based multifactor dimensionality reduction technique to detect epistasis using related individualsTom Cattaert, Víctor Urrea, Adam C Naj, et al.
Journal of Internal Medicine|March 28, 2022
Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs)Cristina Gálvez, Víctor Urrea, Maria Del Carmen Garcia-Guerrero, et al.
The Journal of Infectious Diseases|November 4, 2015
Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral TherapySara Morón-López, Elisabet Gómez-Mora, Maria Salgado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2018
Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected IndividualsSara Morón-López, Jordi Navarro, Montse Jimenez, et al.
Microbiome|May 13, 2019
Evolution of the gut microbiome following acute HIV-1 infectionMuntsa Rocafort, Marc Noguera-Julian, Javier Rivera, et al.
Viruses|June 27, 2024
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope GlycoproteinRaquel Ortiz, Ana Barajas, Anna Pons-Grífols, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2018
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIsMaria C Puertas, Elisabet Gómez-Mora, José R Santos, et al.
Frontiers in Immunology|May 16, 2022
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic IndividualsEdwards Pradenas, Maria Ubals, Víctor Urrea, et al.
The Journal of Infectious Diseases|July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral TherapySilvia Bernal, Maria C Puertas, Sara Morón-López, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2020
Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV-1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)Arkaitz Imaz, Juan M Tiraboschi, Jordi Niubó, et al.
Pageof 3